HK Stock MarketDetailed Quotes

CLARITY MEDICAL (01406)

Watchlist
  • 0.355
  • 0.0000.00%
Market Closed Apr 17 09:21 CST
190.40MMarket Cap-6.34P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CLARITY MEDICAL (01406) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2025
(Q6)Sep 30, 2024
(FY)Mar 31, 2024
(Q6)Sep 30, 2023
(FY)Mar 31, 2023
(Q6)Sep 30, 2022
(FY)Mar 31, 2022
(FY)Mar 31, 2021
(FY)Mar 31, 2020
(FY)Mar 31, 2019
Turnover
-4.87%181.64M
-14.18%87.2M
-10.72%190.93M
-5.65%101.61M
-5.06%213.85M
--107.69M
1.28%225.24M
1.83%222.38M
5.70%218.38M
64.18%206.6M
Operating income
-4.87%181.64M
-14.18%87.2M
-10.72%190.93M
-5.65%101.61M
-5.06%213.85M
107.69M
1.28%225.24M
1.83%222.38M
5.70%218.38M
64.18%206.6M
Operating expenses
Gross profit
Employee expense
----
17.93%-23.95M
-16.18%-61.06M
-23.16%-29.18M
-25.06%-52.56M
---23.69M
-15.70%-42.02M
16.15%-36.32M
-35.08%-43.32M
-105.66%-32.07M
Depreciation and amortization
71.52%-10.65M
34.41%-11.17M
-50.10%-37.38M
-74.00%-17.03M
-12.73%-24.91M
---9.79M
17.31%-22.09M
-10.66%-26.72M
-26.14%-24.15M
-241.46%-19.14M
Impairment and provision
88.53%-3.45M
---7.3M
---30.05M
----
----
----
----
----
----
----
-Impairment of property, machinery and equipment
81.20%-3.45M
---2.46M
---18.33M
----
----
----
----
----
----
----
-Other impairment is provision
----
---4.84M
---11.72M
----
----
----
----
----
----
----
Special items of operating profit
----
20.22%-61.82M
-3.29%-142.31M
-21.87%-77.48M
2.49%-137.78M
---63.58M
-23.27%-141.3M
1.72%-114.62M
-1.68%-116.63M
-59.20%-114.7M
Operating profit
22.87%-17.03M
-5,637.93%-79.87M
-307.73%-22.08M
-107.02%-1.39M
10.63M
-55.67%19.82M
30.45%44.72M
-15.75%34.28M
24.86%40.69M
Financing cost
----
47.56%-635K
-32.72%-2.02M
-189.02%-1.21M
-96.27%-1.53M
---419K
13.95%-777K
19.01%-903K
9.79%-1.12M
-74.58%-1.24M
Earning before tax
24.15%-17.67M
-2,707.54%-81.9M
-328.11%-23.3M
-115.32%-2.92M
10.21M
-56.53%19.05M
32.11%43.82M
-15.93%33.17M
23.76%39.45M
Tax
----
-127.47%-900K
2,327.37%6.1M
242.43%3.28M
95.07%-274K
---2.3M
30.97%-5.56M
-18.70%-8.05M
27.98%-6.78M
-79.67%-9.41M
After-tax profit from continuing operations
7.24%-18.57M
-2,275.21%-75.79M
-353.02%-20.02M
-123.65%-3.19M
7.91M
-62.28%13.49M
35.56%35.77M
-12.16%26.39M
12.76%30.04M
Earning after tax
60.65%-29.82M
7.24%-18.57M
-2,275.21%-75.79M
-353.02%-20.02M
-123.65%-3.19M
7.91M
-62.28%13.49M
35.56%35.77M
-12.16%26.39M
12.76%30.04M
Profit attributable to shareholders
7.24%-18.57M
-2,275.21%-75.79M
-353.02%-20.02M
-123.65%-3.19M
7.91M
-62.28%13.49M
35.56%35.77M
-12.16%26.39M
12.76%30.04M
Basic earnings per share
7.89%-0.035
-2,300.00%-0.144
-353.33%-0.038
-117.14%-0.006
0.015
-63.16%0.035
-100.00%0.095
-17.11%5.6K
6.76K
Diluted earnings per share
7.89%-0.035
-2,300.00%-0.144
-353.33%-0.038
-117.14%-0.006
0.015
-63.16%0.035
-100.00%0.095
-15.28%5.54K
6.54K
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Auditor
--
--
Ernst & Young
--
Ernst & Young
--
PwC
PwC
PwC
PwC
(FY)Mar 31, 2025(Q6)Sep 30, 2024(FY)Mar 31, 2024(Q6)Sep 30, 2023(FY)Mar 31, 2023(Q6)Sep 30, 2022(FY)Mar 31, 2022(FY)Mar 31, 2021(FY)Mar 31, 2020(FY)Mar 31, 2019
Turnover -4.87%181.64M-14.18%87.2M-10.72%190.93M-5.65%101.61M-5.06%213.85M--107.69M1.28%225.24M1.83%222.38M5.70%218.38M64.18%206.6M
Operating income -4.87%181.64M-14.18%87.2M-10.72%190.93M-5.65%101.61M-5.06%213.85M107.69M1.28%225.24M1.83%222.38M5.70%218.38M64.18%206.6M
Operating expenses
Gross profit
Employee expense ----17.93%-23.95M-16.18%-61.06M-23.16%-29.18M-25.06%-52.56M---23.69M-15.70%-42.02M16.15%-36.32M-35.08%-43.32M-105.66%-32.07M
Depreciation and amortization 71.52%-10.65M34.41%-11.17M-50.10%-37.38M-74.00%-17.03M-12.73%-24.91M---9.79M17.31%-22.09M-10.66%-26.72M-26.14%-24.15M-241.46%-19.14M
Impairment and provision 88.53%-3.45M---7.3M---30.05M----------------------------
-Impairment of property, machinery and equipment 81.20%-3.45M---2.46M---18.33M----------------------------
-Other impairment is provision -------4.84M---11.72M----------------------------
Special items of operating profit ----20.22%-61.82M-3.29%-142.31M-21.87%-77.48M2.49%-137.78M---63.58M-23.27%-141.3M1.72%-114.62M-1.68%-116.63M-59.20%-114.7M
Operating profit 22.87%-17.03M-5,637.93%-79.87M-307.73%-22.08M-107.02%-1.39M10.63M-55.67%19.82M30.45%44.72M-15.75%34.28M24.86%40.69M
Financing cost ----47.56%-635K-32.72%-2.02M-189.02%-1.21M-96.27%-1.53M---419K13.95%-777K19.01%-903K9.79%-1.12M-74.58%-1.24M
Earning before tax 24.15%-17.67M-2,707.54%-81.9M-328.11%-23.3M-115.32%-2.92M10.21M-56.53%19.05M32.11%43.82M-15.93%33.17M23.76%39.45M
Tax -----127.47%-900K2,327.37%6.1M242.43%3.28M95.07%-274K---2.3M30.97%-5.56M-18.70%-8.05M27.98%-6.78M-79.67%-9.41M
After-tax profit from continuing operations 7.24%-18.57M-2,275.21%-75.79M-353.02%-20.02M-123.65%-3.19M7.91M-62.28%13.49M35.56%35.77M-12.16%26.39M12.76%30.04M
Earning after tax 60.65%-29.82M7.24%-18.57M-2,275.21%-75.79M-353.02%-20.02M-123.65%-3.19M7.91M-62.28%13.49M35.56%35.77M-12.16%26.39M12.76%30.04M
Profit attributable to shareholders 7.24%-18.57M-2,275.21%-75.79M-353.02%-20.02M-123.65%-3.19M7.91M-62.28%13.49M35.56%35.77M-12.16%26.39M12.76%30.04M
Basic earnings per share 7.89%-0.035-2,300.00%-0.144-353.33%-0.038-117.14%-0.0060.015-63.16%0.035-100.00%0.095-17.11%5.6K6.76K
Diluted earnings per share 7.89%-0.035-2,300.00%-0.144-353.33%-0.038-117.14%-0.0060.015-63.16%0.035-100.00%0.095-15.28%5.54K6.54K
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions ----Unqualified Opinion--Unqualified Opinion--Unqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified Opinion
Auditor ----Ernst & Young--Ernst & Young--PwCPwCPwCPwC

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +1.04%
Sample Name
Sample Code
 -4.60%
Sample Name
Sample Code
 -6.30%
4
CNOOC
00883
-6.32%
5
YANCHANG PETRO
00346
-8.99%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.87%
Sample Name
Sample Code
 +10.97%
Sample Name
Sample Code
 +6.23%
4
INESA Intelligent Tech Inc.
600602
+6.13%
5
Business-intelligence Of Oriental Nations Corporation
300166
+1.83%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -